EOM Pharmaceuticals Holdings, Inc. – OTC:IMUC

EOM Pharmaceuticals Holdings stock price today

$0.061
-0.10
-63.86%
Financial Health
0
1
2
3
4
5
6
7
8
9

EOM Pharmaceuticals Holdings stock price yearly change

-41.72%
year

EOM Pharmaceuticals Holdings key metrics

Market Cap
1.96M
Enterprise value
N/A
P/E
0.01
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
0.30
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

EOM Pharmaceuticals Holdings stock price history

EOM Pharmaceuticals Holdings stock forecast

EOM Pharmaceuticals Holdings financial statements

EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Profit margin
Dec 2022 0 -464.52K
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Debt to assets
Jun 2018 3829392 401.94K 10.5%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Cash Flow
Dec 2022 -687.93K 0 750K
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0

EOM Pharmaceuticals Holdings alternative data

EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Employee count
Aug 2023 3
Sep 2023 3
Oct 2023 3
Nov 2023 3
Dec 2023 3
Jan 2024 3
Feb 2024 3
Mar 2024 3
Apr 2024 3
May 2024 3
Jun 2024 3
Jul 2024 3

EOM Pharmaceuticals Holdings other data

EOM Pharmaceuticals Holdings, Inc. (OTC:IMUC): Insider trades (number of shares)
Period Buy Sel
Feb 2015 149600 0
Nov 2015 10000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GENGOS ANDREW director
Common Stock 10,000 N/A N/A
Option
YU JOHN S director
Common Stock 25,000 N/A N/A
Option
YU JOHN S director
Stock Option (right to buy) 25,000 N/A N/A
Purchase
FRACTOR DAVID officer: VP of Finance
Warrant to Purchase Common Stock 11,667 N/A N/A
Purchase
FRACTOR DAVID officer: VP of Finance
Common Stock 16,667 N/A N/A
Purchase
GRINGERI ANTHONY officer: Senior VP Strategic Re..
Warrant to Purchase Common Stock 21,000 N/A N/A
Purchase
GRINGERI ANTHONY officer: Senior VP Strategic Re..
Common Stock 30,000 N/A N/A
Purchase
GENGOS ANDREW director
Warrant to Purchase Common Stock 28,933 N/A N/A
Purchase
GENGOS ANDREW director
Common Stock 41,333 N/A N/A
Purchase
GRINGERI ANTHONY officer: Senior VP Strategic Re..
Common Stock 11,000 N/A N/A
Patent
Application
Filling date: 22 Oct 2018 Issue date: 12 Sep 2019
  • What's the price of EOM Pharmaceuticals Holdings stock today?

    One share of EOM Pharmaceuticals Holdings stock can currently be purchased for approximately $0.06.

  • When is EOM Pharmaceuticals Holdings's next earnings date?

    Unfortunately, EOM Pharmaceuticals Holdings's (IMUC) next earnings date is currently unknown.

  • Does EOM Pharmaceuticals Holdings pay dividends?

    No, EOM Pharmaceuticals Holdings does not pay dividends.

  • How much money does EOM Pharmaceuticals Holdings make?

    EOM Pharmaceuticals Holdings has a market capitalization of 1.96M.

  • What is EOM Pharmaceuticals Holdings's stock symbol?

    EOM Pharmaceuticals Holdings, Inc. is traded on the OTC under the ticker symbol "IMUC".

  • What is EOM Pharmaceuticals Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of EOM Pharmaceuticals Holdings?

    Shares of EOM Pharmaceuticals Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does EOM Pharmaceuticals Holdings have?

    As Jul 2024, EOM Pharmaceuticals Holdings employs 3 workers.

  • When EOM Pharmaceuticals Holdings went public?

    EOM Pharmaceuticals Holdings, Inc. is publicly traded company for more then 18 years since IPO on 19 Sep 2006.

  • What is EOM Pharmaceuticals Holdings's official website?

    The official website for EOM Pharmaceuticals Holdings is eompharma.com.

  • Where are EOM Pharmaceuticals Holdings's headquarters?

    EOM Pharmaceuticals Holdings is headquartered at 30721 Russell Ranch Rd Ste 140, Westlake Village, CALIFORNIA.

  • How can i contact EOM Pharmaceuticals Holdings?

    EOM Pharmaceuticals Holdings's mailing address is 30721 Russell Ranch Rd Ste 140, Westlake Village, CALIFORNIA and company can be reached via phone at +1 818 264 2300.

EOM Pharmaceuticals Holdings company profile:

EOM Pharmaceuticals Holdings, Inc.

eompharma.com
Exchange:

OTC

Full time employees:

3

Industry:

Biotechnology

Sector:

Healthcare

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.

30721 Russell Ranch Rd Ste 140
Westlake Village, CALIFORNIA 07645

CIK: 0000822411
ISIN: US4525362046
CUSIP: 452536204